Piramal Enterprises sells clinical research business to Indoco

Discussion in 'Must-Read Interviews, Articles & News Items' started by Vidhi Khanna, Apr 2, 2015.

  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    427
    Likes Received:
    55
    Mumbai: Indian drugmaker Indoco Remedies Ltd said on Wednesday it would buy Piramal Enterprises Ltd’s clinical research business for an undisclosed amount to reduce its research costs.

    Piramal Clinical Research, the Hyderabad-based contract research organisation (CRO), conducts clinical trials for generic drugs, and is approved by the US and UK health regulators, Indoco said.

    The business is being acquired on a going-concern basis, said Indoco, a mid-sized firm that makes both finished drugs and drug ingredients for export across 35 countries.

    Piramal, a conglomerate with businesses in healthcare and financial services, said the CRO was not a strategic fit for the company and formed a “relatively small” portion of its entire business.

    Piramal does not expect any financial impact from the sale, which is expected to be completed by 6 April, the company said in a separate statement.

    Read more at: https://www.livemint.com/Companies/RtvGnFLsrdBvr3KTzw941J/Indoco-Remedies-to-buy-Piramals-clinical-research-business.html
     
Loading...